Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
about
Developmental and pathological angiogenesis in the central nervous systemStem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain siteBeneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.Mmp-9, a potential target for cerebral ischemic treatment.Increased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke.The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia.Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition.Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injuryNeurovascular injury in acute hyperglycemia and diabetes: A comparative analysis in experimental stroke.Stem cell-paved biobridge facilitates neural repair in traumatic brain injury.Brain distribution and elimination of recombinant human TIMP-1 after cerebral ischemia and reperfusion in rats.Partially purified components of Uncaria sinensis attenuate blood brain barrier disruption after ischemic brain injury in mice.Mannitol-facilitated perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) for detection of experimental cerebral infarction and biochemical analysis.Stem Cell-Induced Biobridges as Possible Tools to Aid Neuroreconstruction after CNS Injury.Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic strokeEffects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.Neuroprotective effects of systemic cerebral endothelial cell transplantation in a rat model of cerebral ischemia.Adoptive regulatory T-cell therapy protects against cerebral ischemia.Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.Inflammatory mechanisms in ischemic stroke: therapeutic approachesBreaking the barrier in stroke: what should we know? A mini-review.The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke.Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia.Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.Deletion of Nuclear Localizing Signal Attenuates Proinflammatory Activity of Prothymosin-Alpha and Enhances Its Neuroprotective Effect on Transient Ischemic Stroke.Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.Early outcome and blood-brain barrier integrity after co-administered thrombolysis and hyperbaric oxygenation in experimental strokeInterrelations between blood-brain barrier permeability and matrix metalloproteinases are differently affected by tissue plasminogen activator and hyperoxia in a rat model of embolic strokeMyeloperoxidase Inhibition Increases Neurogenesis after Ischemic Stroke.Chondroitin sulfate, a major component of the perineuronal net, elicits inward currents, cell depolarization, and calcium transients by acting on AMPA and kainate receptors of hippocampal neurons.Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke.Thrombin/Matrix Metalloproteinase-9-Dependent SK-N-SH Cell Migration is Mediated Through a PLC/PKC/MAPKs/NF-κB Cascade.Exploring molecular mechanism underlying Chinese medicine syndrome: a study on correlation between Chinese medicine syndrome and biomarkers for ischemic stroke.CT volume/density ratio as the marker of ischaemic brain injury.Peroxynitrite Decomposition Catalyst Reduces Delayed Thrombolysis-induced Hemorrhagic Transformation in Ischemia-reperfused Rat Brains.Combining statins with tissue plasminogen activator treatment after experimental and human stroke: a safety study on hemorrhagic transformation.Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells.Kir6.1 knockdown aggravates cerebral ischemia/reperfusion-induced neural injury in mice.Effects of Vitamin D3 on the NADPH Oxidase and Matrix Metalloproteinase 9 in an Animal Model of Global Cerebral Ischemia.
P2860
Q27023250-DE46200C-5386-49B7-A10D-DF71D57C74E3Q27306345-F248BC66-2FA7-4E50-B630-E972134F922BQ33566724-BD446690-05CA-4ADB-80FB-52D9BC509F35Q33612510-AD77976D-CBBB-420B-8598-B2451DC65446Q33889047-299D5ECC-BB17-460E-9CDC-706E01FBF064Q34335614-70E3CD18-C1B2-49BB-987D-0EC8D7F854A9Q34627485-2539F87D-10F6-4F04-9FF0-A059CC1D22E2Q34671588-4A4560AF-C5E7-4B90-9C50-FBA2D28A3012Q35202882-D85037FF-7963-4833-89F7-F526DA02B2F1Q35204205-75403138-5574-4BF2-B796-6F741E060923Q35354948-530BDB03-0C52-450D-AA4A-5C438A285D48Q35642303-F13F2B6B-260E-4FB1-8775-1495334F27FAQ35707046-B4A5BBC9-AD62-418B-8394-10696CB1C2ABQ36379561-8FE8DADC-66A5-4E34-BB78-35EC4EC5FFDEQ36750801-6BCF78D1-8C5C-43CF-8D31-00CF02192581Q36783536-2F59ECB0-3584-43CD-9024-5E121E1B961AQ36964182-A1ABE821-CFC4-462D-B53C-EDBAD52BF5DCQ37107049-81E51BBA-4A89-43BB-826D-632A8A46FCDAQ37612249-4D452801-15E1-4E14-A574-6B19C569F890Q37634142-310D77EB-6F38-4B0D-8704-348D26C56D4CQ38009070-A304E0A1-A6BE-4FEB-BD4A-FA595C294143Q38168582-804CB83F-147F-45D5-AAD4-985F5768FD99Q38196884-82814F47-8CFF-47E9-BA63-6CE4C8C096B4Q38431768-CA76C433-934F-466E-A8C8-2F24C77E4895Q39116577-A9D1864F-AB54-4776-BF09-C8E1EA621D8DQ40127868-98B2207C-1514-42F4-8D80-60FAD874A27BQ41174665-5B69E42E-870C-4E3A-8CEF-4D35AAF2D4F9Q41879966-FA40CA90-79D7-4E10-9D22-8BBE916E09E1Q42124550-BE438A63-D021-4F3D-BC16-23E2A331DEE8Q42713287-1E2576FB-6A04-49EE-83A4-4BF0557C91A3Q45392051-4B380D1D-8E46-4993-B0F5-B3DB0330385BQ46110252-0084E0E3-2EBF-40AE-B83C-708CC7A126C1Q47371190-3486C257-120B-4796-88F4-6B6E23228D71Q47765526-E8065D8F-BBF2-43E2-8BC5-519B783BCAAAQ48157063-5FCF3242-486D-49D3-A561-F6C68587E6B1Q48166886-53618343-CA87-4257-B9D3-10D8D5E3BF4DQ48939391-D9E74EDF-440D-4B1D-8DBE-9BDBE2C44960Q49036874-E9877D7B-21A0-4139-8D75-9A66A0876858Q51003927-A34AF4F9-B526-40B9-9088-705E3CAFA27BQ55031807-B12A247D-3F1A-4C8E-BD97-B5AFE09D0614
P2860
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
@en
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
@nl
type
label
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
@en
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
@nl
prefLabel
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
@en
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
@nl
P2093
P2860
P1433
P1476
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
@en
P2093
Anna Rosell
Changhong Xing
Christian Foerch
Karen L Furie
Kyung-Pil Park
Woo Jean Kim
P2860
P304
P356
10.1161/STROKEAHA.109.554824
P407
P577
2009-06-25T00:00:00Z